![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, July 29, 2018 10:19:04 AM
Not only will MD's not know about it, but 99.9% of the general public does/will not. That is a big challenge ahead for BIEL to provide the exposure to the product, which will take time. Partnerships developed in the US will help provide the education that is needed...such as NHS. As mentioned by Paul, once the "cash loosens up", PR campaigns can begin, and a big name hospital being worked with help the PR. General public OTC strategy is secondary at the moment according to mgmt. FDA approval will help in many different ways, but is doesn't tell the public about the product.
A lot of positive action on the horizon, but IF to become a household name, or gain widespread recognition for that matter will take a few years....IMO.. thats me thinking??
![smile](/images/emoticon01.gif)
Yes, a "head scratcher" for me being at .0029.
In for the long haul.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM